PMC:7321036 / 47153-47305
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T378 | 31-36 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T233 | 131-139 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T234 | 142-151 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T590 | 10-14 | http://purl.obolibrary.org/obo/CLO_0009524 | denotes | Vero |
| T591 | 10-14 | http://purl.obolibrary.org/obo/CLO_0050515 | denotes | Vero |
| T592 | 21-25 | http://purl.obolibrary.org/obo/CLO_0001601 | denotes | A549 |
| T593 | 21-25 | http://purl.obolibrary.org/obo/CLO_0050025 | denotes | A549 |
| T594 | 21-25 | http://purl.obolibrary.org/obo/CLO_0054264 | denotes | A549 |
| T595 | 21-25 | http://purl.obolibrary.org/obo/CLO_0054265 | denotes | A549 |
| T596 | 21-25 | http://purl.obolibrary.org/obo/CLO_0054266 | denotes | A549 |
| T597 | 21-25 | http://purl.obolibrary.org/obo/CLO_0054267 | denotes | A549 |
| T598 | 21-25 | http://purl.obolibrary.org/obo/CLO_0054268 | denotes | A549 |
| T599 | 21-25 | http://purl.obolibrary.org/obo/CLO_0054269 | denotes | A549 |
| T600 | 31-36 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T331 | 63-72 | Chemical | denotes | inhibitor | http://purl.obolibrary.org/obo/CHEBI_35222 |
| T332 | 93-106 | Chemical | denotes | CDK inhibitor | http://purl.obolibrary.org/obo/CHEBI_82665 |
| T333 | 97-106 | Chemical | denotes | inhibitor | http://purl.obolibrary.org/obo/CHEBI_35222 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T331 | 93-106 | http://purl.obolibrary.org/obo/GO_0004861 | denotes | CDK inhibitor |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 994 | 107-117 | Chemical | denotes | dinaciclib | MESH:C553669 |
| 995 | 131-151 | Disease | denotes | SARS-CoV-2 infection | MESH:C000657245 |
| 996 | 15-17 | CellLine | denotes | E6 | CVCL:4582 |
| 997 | 21-30 | CellLine | denotes | A549-ACE2 | CVCL:0023 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T315 | 0-152 | Sentence | denotes | (J and K) Vero E6 or A549-ACE2 cells were treated with PIKFYVE inhibitor apilimod (J) or the CDK inhibitor dinaciclib (K) prior to SARS-CoV-2 infection. |